Nsphfh

Study

New Studies Provide Hope for HIV Patients

Shelby Davidson

Written by: Shelby Davidson

Shelby Davidson

With experience covering all things related to the dating world, I have produced content for sites like Elite Daily and The Lala. While a majority of my time is spent as an editorial assistant writing articles and transcribing interviews, you can also find me in the gym, listening to Drake or at a hipster coffee shop.

Edited by: Lillian Castro

Lillian Castro

Lillian Guevara-Castro brings more than 30 years of journalism experience to ensure DatingAdvice articles and reports have been edited for overall clarity, accuracy, and reader engagement.

Discuss This! Discuss This!
Advertiser Disclosure

Researchers and scientists around the world have constantly struggled to find an effective vaccine for HIV. Discovering methods for anti-HIV strategies once a patient is infected has been far from easy as well.

However, recent research on the disease shows that a solution is coming soon. Journals mBio and PLOS Pathogens have published a few studies published that are providing hope.

Study: Alternative Approach to Current Anti-HIV Strategies

Because interruption of current antiretroviral therapy results in virus rebound and progression to AIDS, HIV-infected patients typically keep up with the treatment for life.

But now scientists from the Florida campus of the Scripps Research Institute (TSRI) have discovered there is a solution to this problem.

Their new study, published in the journal mBio, shows a natural compound called Cortistatin A prevents HIV-infected cells from replicating by reducing levels of viral messenger RNA, which is a blueprint for more infection.

“In our proposed model, didehydro-Cortistatin A inhibits the viral transcriptional activator, Tat, far more completely, delaying or even halting viral replication, reactivation and replenishment of the latent viral reservoir,” said Susana Valente, a TSRI associate professor who led the study.

This compound establishes a near-permanent state of latency and greatly decreases the virus’ ability to reactivate. Results from the study highlight an alternative to a widely known anti-HIV strategy known as “kick and kill.”

Study: Investigating Neutralized Antibodies for HIV Vaccine

Although an official vaccination that protects against HIV has yet to be made, two studies published in PLOS Pathogens shed light on the role of neutralized antibodies (Nabs) in helping prevent the virus from spreading.

Nabs are immune proteins that can trigger the elimination of a virus before it causes chronic infection. In a study last year, researchers had already discovered how to create them in those infected with HIV-1.

Results from 21 women showed Nabs mount a potent response against various HIV sub-types.

The second study published under Dr. Alexandra Trkola, of the University of Zurich, Switzerland, and her colleagues focused on the effect of Nabs in those infected with HIV/AIDS by cell-to-cell contact.

While there was a decrease in activity for the Nabs, losses varied based on virus strain and antibody. In addition, some Nabs retained activity and inhibited the virus prior to binding to the CD4 receptor on T cells.

Trkola and her team displayed that cell-to-cell transmission makes the virus far more prone to mutation strains that can escape immune control.

With the help of studies like these and the continuation of advancements in science, there may one day be a cure for HIV/AIDS. Although HIV incidence remains around 50,000 new infections per year, every day is a step in the right direction.

Advertiser Disclosure

DatingAdvice.com is a free online resource that offers valuable content and comparison services to users. To keep this resource 100% free, we receive compensation from many of the offers listed on the site. Along with key review factors, this compensation may impact how and where products appear across the site (including, for example, the order in which they appear). DatingAdvice.com does not include the entire universe of available offers. Editorial opinions expressed on the site are strictly our own and are not provided, endorsed, or approved by advertisers.

Our Editorial Review Policy

Our site is committed to publishing independent, accurate content guided by strict editorial guidelines. Before articles and reviews are published on our site, they undergo a thorough review process performed by a team of independent editors and subject-matter experts to ensure the content’s accuracy, timeliness, and impartiality. Our editorial team is separate and independent of our site’s advertisers, and the opinions they express on our site are their own. To read more about our team members and their editorial backgrounds, please visit our site’s About page.